Finance

Lists
6MK:FRA
Merck & Co Inc
€ 130.28
+0.57%
(+0.74) 1D
10-р сарын 12, 13:14:47 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6MK...
Open
€ 130.32
High
€ 130.32
Low
€ 129.90
Mkt. cap
359.22Т
Avg. vol.
469.00
Volume
170.00
52-wk high
€ 134.54
52-wk low
€ 71.00
No. of employees
74 мян
Open
€ 130.32
High
€ 130.32
Low
€ 129.90
Mkt. cap
359.22Т
Avg. vol.
469.00
Volume
170.00
52-wk high
€ 134.54
52-wk low
€ 71.00
No. of employees
74 мян
News stories
From web sources and news partners
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74 мян
Founded1891 оны 1-р сарын 1
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
17.28 тэрбум
16.40 тэрбум
16.29 тэрбум
16.61 тэрбум
Cost of goods sold
3.74 тэрбум
4.30 тэрбум
3.88 тэрбум
4.13 тэрбум
Cost of revenue
3.74 тэрбум
4.30 тэрбум
3.88 тэрбум
4.13 тэрбум
Research and development expenses
4.00 тэрбум
4.00 тэрбум
3.56 тэрбум
9.74 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.48 тэрбум
2.73 тэрбум
2.57 тэрбум
2.78 тэрбум
Operating expense
6.48 тэрбум
6.73 тэрбум
6.12 тэрбум
12.52 тэрбум
Total operating expenses
10.23 тэрбум
11.02 тэрбум
10.00 тэрбум
16.65 тэрбум
Operating income
7.05 тэрбум
5.38 тэрбум
6.29 тэрбум
-40.00 сая
Other non operating income
-
41.00 сая
42.00 сая
59.00 сая
EBT including unusual items
6.74 тэрбум
3.42 тэрбум
-3.53 тэрбум
-683.00 сая
EBT excluding unusual items
6.76 тэрбум
4.98 тэрбум
5.85 тэрбум
-508.00 сая
Income tax expense
958.00 сая
458.00 сая
709.00 сая
654.00 сая
Effective tax rate
14.20%
13.39%
-20.06%
-95.75%
Other operating expenses
-
-
-
-
Net income
5.78 тэрбум
2.96 тэрбум
-4.24 тэрбум
-1.34 тэрбум
Net profit margin
33.49%
18.07%
-26.03%
-8.04%
Earnings per share
2.58
2.04
-1.28
-0.13
Interest and investment income
96.00 сая
69.00 сая
35.00 сая
35.00 сая
Interest expense
-327.00 сая
-411.00 сая
-479.00 сая
-525.00 сая
Net interest expenses
-231.00 сая
-342.00 сая
-444.00 сая
-490.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
8.15 тэрбум
6.79 тэрбум
7.69 тэрбум
1.43 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс